Invitae CEO Sean George told CNBC he believes genetic testing will be central to health-care decisions in five to 10 years. Originally published at CNBC
Find More
Trending News
- Why Amazon’s Workers Sided With the Company Over a Union
- Airbnb CEO says company will need millions more hosts to meet surging demand
- Soona raises $10.2M to make remote photo and video shoots easy
- Nelo raises $3M to grow ‘buy now, pay later’ in Mexico
- Reform the US low-income broadband program by rebuilding Lifeline
- Facebook’s decision-review body to take “weeks” longer over Trump ban call
- Why UBS believes Netflix is the long-term winner in streaming
- ‘One-thirtieth’ of the way back: Main Street expects theme parks to jump-start California recovery
- Morgan Stanley had $911 million in first-quarter losses tied to Archegos fund meltdown
- Sunrun upgraded to overweight at Piper Sandler after shares get cut in half